The International Liver Congress 2014 (ILC 2014), the 49th annual meeting of the European Association for the Study of the Liver (EASL), took place in London, UK, 9-13th April 2014.

Conference highlights

New WHO guidelines

WHO recommends global use of newest hepatitis C drugs, urges price reductions

HIV and HCV co-infection

Sofosbuvir/ledipasvir produces early cure for 100% of people with HIV and HCV co-infection

New EASL guidelines

European liver specialists recommend 'mix-and-match' approach to new hepatitis C drugs

aidsmap news from ILC 2014

← First1Next →

Editors' picks from other sources

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

More hepatitis news

For more information on viral hepatitis visit

Infohep is a hepatitis project we're working on in partnership with the European Liver Patients Association (ELPA).

Visit >

Official conference website

Find out more about the conference and view the programme on the official conference website.

Visit the conference website >